NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-CA-20-041 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-AI-20-007 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications from single institutions or consortia of institutions to participate in the Asthma and Allergic Diseases Cooperative Research Centers (AADCRC) program. The program will support centers that integrate clinical and translational research to conduct studies on the mechanisms underlying the onset and progression of diseases of interest, including asthma, rhinitis (allergic and non-allergic), chronic rhinosinusitis, atopic dermatitis, food allergy, and drug allergy. The overarching goal of the program is to improve the understanding of the pathogenesis of these conditions and to provide a rational foundation for new, effective treatments and prevention strategies.
Long Acting Treatments for HIV and HIV-Associated Co-Infections (R61/R33 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-20-024 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity is to stimulate new and innovative multidisciplinary research in the area of long acting therapeutics for HIV and HIV-associated tuberculosis (TB) and viral hepatitis B and C. Applications are sought that lead to new effective therapies for administration once per month or less frequently as oral, injectable, implantable, or transdermal products.
Notice NOT-CA-20-037 from the NIH Guide for Grants and Contracts
Notice NOT-HG-20-029 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-DC-20-001 from the NIH Guide for Grants and Contracts. The over-arching goal of this NIDCD R25 program is to support educational activities that foster a better understanding of biomedical research and its implications in the areas of auditory and vestibular research. The complexity of auditory and vestibular biology processes provide our hearing and balance function. Interruption of these processes may occur from a variety of factors, including genetic, environmental and pathogenic agents, and often results in the loss of hearing and balance function. While loss or impairment of these functions are most often non-life-threatening, the disruption to quality of life is substantial. Since August of 2007, the National Institute on Deafness and Other Communication Disorders (NIDCD) (http://www.nidcd.nih.gov/) has supported a special topics course in auditory and vestibular biology. The two to three week course, Biology of the Inner Ear, has been held at the Marine Biological Laboratory in Woods Hole, MA, and has brought together outstanding faculty to provide hands-on instruction to participants. It is the continued intent of the NIDCD to foster the advancement of research methodologies and technologies to improve, hasten and implement new treatments for these disorders and impairments. It is based on this template of excellence that the NIDCD invites R25 applications for support of a special topics course in the auditory and vestibular sciences. The purpose of this five-year initiative is to support three courses to be offered each in years 2021, 2023, and 2025. This will allow for a sustained specialized topics course that provides lecture and hands-on research exposure to the auditory and vestibular sciences. The target audience envisioned for this course consists of advanced graduate students, post-doctoral fellows and established early stage research investigators.
Notice NOT-OD-20-089 from the NIH Guide for Grants and Contracts
Notice NOT-CA-20-040 from the NIH Guide for Grants and Contracts
Notice NOT-CA-20-032 from the NIH Guide for Grants and Contracts
Notice NOT-DE-20-017 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-20-143 from the NIH Guide for Grants and Contracts. Nearly 40,000 people in the U.S. die from firearm-related deaths each year, primarily from suicide (60%) or homicide (37%), and many more have experienced non-fatal firearm injuries, both intentional and nonintentional. The Joint Explanatory Statement accompanying the FY2020 Further Consolidated Appropriations Act (H.R. 1865) included funding for the NIH to conduct research on firearm injury and mortality prevention and recommended that NIH take a comprehensive approach to studying the underlying causes and evidence-based methods of prevention of firearm injury, including crime prevention. Within the legislative mandates and limitations of NIH funding (NOT-OD-20-068, NOT-OD-20-066), the NIH encourages research to improve understanding of the determinants of firearm injury, the identification of those at risk of firearm injury (including both victims and perpetrators), the development and evaluation of innovative interventions to prevent firearm injury and mortality, and the examination of approaches to improve the implementation of existing, evidence-based interventions to prevent firearm injury and mortality.
Funding Opportunity PA-20-142 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) will award Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (T32) to eligible, domestic institutions to enhance predoctoral and postdoctoral research training, including short-term research training, and help ensure that a diverse and highly trained workforce is available to meet the needs of the Nations biomedical, behavioral, and clinical research agenda. Research training programs are expected to incorporate didactic, research, and career development elements to prepare trainees for careers that will have a significant impact on the health-related research needs of the Nation. Programs proposing only short-term predoctoral research training should not apply to this announcement, but rather to the Kirschstein-NRSA Short-Term Institutional Research Training Grant Program (T35) exclusively reserved for predoctoral, short-term research training (see PA-18-404). This Funding Opportunity Announcement (FOA) does not allow appointed trainees to lead an independent clinical trial, but does allow them to obtain research experience in a clinical trial led by a mentor or co-mentor.
Notice NOT-CA-20-035 from the NIH Guide for Grants and Contracts
Notice NOT-CA-20-034 from the NIH Guide for Grants and Contracts
Notice NOT-AG-20-021 from the NIH Guide for Grants and Contracts
Notice NOT-MH-20-027 from the NIH Guide for Grants and Contracts
Funding Opportunity PA-20-141 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages formative research, intervention development, and pilot-testing of interventions. Primary scientific areas of focus include the feasibility, tolerability, acceptability and safety of novel or adapted interventions that target HIV prevention or treatment. For the purposes of this FOA, intervention is defined to include behavioral, social, or structural approaches, as well as combination biomedical and behavioral, social, or structural approaches that prevent acquisition and transmission of HIV infection, or improve clinical outcomes for persons who are HIV infected, or both.
Notice NOT-OD-20-080 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-HD-21-005 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support studies which utilize emerging genomic technologies to identify variants which predict risk for pregnancy loss in subsequent pregnancies beyond standard karyotype approaches.
Notice NOT-RM-20-009 from the NIH Guide for Grants and Contracts